BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 15862616)

  • 1. The role of lymphadenectomy in high-grade invasive bladder cancer.
    Stein JP; Skinner DG
    Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer.
    Quek ML; Sanderson KM; Daneshmand S; Stein JP
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1007-16. PubMed ID: 15606329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenectomy in bladder cancer: a review.
    Buscarini M; Josephson DY; Stein JP
    Urol Int; 2007; 79(3):191-9. PubMed ID: 17940349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
    Bruins HM; Stein JP
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer.
    Ather MH; Alam Z; Jamshaid A; Siddiqui KM; Sulaiman MN
    Urol J; 2008; 5(2):94-8. PubMed ID: 18592461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer.
    Sanderson KM; Stein JP; Skinner DG
    Urol Oncol; 2004; 22(3):205-11; discussion 212-3. PubMed ID: 15271318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of ratio based lymph node staging for bladder cancer.
    Herr HW
    J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
    Mills RD; Fleischmann A; Studer UE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
    Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
    Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
    Stein JP; Penson DF; Cai J; Miranda G; Skinner EC; Dunn MA; Groshen S; Lieskovsky G; Skinner DG
    J Urol; 2007 Mar; 177(3):876-81; discussion 881-2. PubMed ID: 17296365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.